In a filing, AlloVir Inc revealed its General Counsel Miller Edward unloaded Company’s shares for reported $180.0 on Jan 10 ’25. In the deal valued at $0.44 per share,409 shares were sold. As a result of this transaction, Miller Edward now holds 153,541 shares worth roughly $1.42 million.
Then, Hagen Brett R sold 332 shares, generating $146 in total proceeds. Upon selling the shares at $0.44, the Chief Accounting Officer now owns 68,174 shares.
Before that, Sinha Vikas sold 979 shares. AlloVir Inc shares valued at $431 were divested by the insider at a price of $0.44 per share. As a result of the transaction, Sinha Vikas now holds 1,139,915 shares, worth roughly $10.58 million.
BofA Securities downgraded its AlloVir Inc [ALVR] rating to an Underperform from a a Buy in a research note published on December 26, 2023; the price target was decreased to $1 from $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late December from “an Overweight” to “a Neutral”. Leerink Partners also remained covering ALVR and has decreased its forecast on December 22, 2023 with a “Market perform” recommendation from previously “an Outperform” rating. JP Morgan revised its rating on December 22, 2023. It rated ALVR as “an Underweight” which previously was an “an Overweight”.
Price Performance Review of ALVR
On Friday, AlloVir Inc [NASDAQ:ALVR] saw its stock jump 3.11% to $9.28. Over the last five days, the stock has lost -8.11%. AlloVir Inc shares have fallen nearly -3.93% since the year began. Nevertheless, the stocks have fallen -40.23% over the past one year. While a 52-week high of $24.15 was reached on 01/07/25, a 52-week low of $7.96 was recorded on 01/16/25. SMA at 50 days reached $12.06, while 200 days put it at $16.36.
Levels Of Support And Resistance For ALVR Stock
The 24-hour chart illustrates a support level at 8.63, which if violated will result in even more drops to 7.98. On the upside, there is a resistance level at 9.97. A further resistance level may holdings at 10.65. The Relative Strength Index (RSI) on the 14-day chart is 38.19, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.00%. Stochastics %K at 19.93% indicates the stock is a buying.
How much short interest is there in AlloVir Inc?
A steep rise in short interest was recorded in AlloVir Inc stocks on 2024-10-31, dropping by -1.55 million shares to a total of 3.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 5.5 million shares. There was a decline of -39.21%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 18, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $17 price target.
